Nephron Corporation in Duluth, Georgia - Dialysis Center

Nephron Corporation is a medicare approved dialysis facility center in Duluth, Georgia and it has 16 dialysis stations. It is located in Gwinnett county at 3770 Howell Ferry Road, Duluth, GA, 30096. You can reach out to the office of Nephron Corporation at (678) 495-0420. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Nephron Corporation has the following ownership type - Profit. It was first certified by medicare in April, 2009. The medicare id for this facility is 112809 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameNephron Corporation
Location3770 Howell Ferry Road, Duluth, Georgia
No. of Dialysis Stations 16
Medicare ID112809
Managed ByIndependent
Ownership TypeProfit
Late Shifts No

Contact Information


3770 Howell Ferry Road, Duluth, Georgia, 30096
(678) 495-0420

Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Nephron Corporation from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data9

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center25
    Adult patient months included in Kt/V greater than or equal to 1.2187
    Percentage of adult patients getting regular hemodialysis at the center83
    Percentage of pediatric patients getting regular hemodialysis at the center

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Nephron Corporation with elevated calcium levels.

Patients with hypercalcemia27
Hypercalcemia patient months191
Hypercalcemia patients with serumcalcium greater than 10.2 mg3
Patients with Serumphosphor27
Patients with Serumphosphor less than 3.5 mg/dL21
Patients with Serumphosphor from 3.5 to 4.5 mg/dL25
Patients with Serumphosphor from 4.6 to 5.5 mg/dL24
Patients with Serumphosphor from 5.6 to 7 mg/dL21
Patients with Serumphosphor greater than 7 mg/dL10

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 24
Patient months included in arterial venous fistula and catheter summaries 136
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment76
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer10

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary18
Hospitalization Rate in facility145.2 (As Expected)
Hospitalization Rate: Upper Confidence Limit368.1
Hospitalization Rate: Lower Confidence Limit61.6

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Nephron Corporation were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility27.3 (As Expected)
Readmission Rate: Upper Confidence Limit44.5
Readmission Rate: Lower Confidence Limit14.1